• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein GPR107 (GPR107), Truncated

ACP01047

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01047 Target NameGPR107
Target Synonyms(Lung seven transmembrane receptor 1)FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range40-263aa
Mol Weight32.4 kDaProtein LengthPartial
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5VW38
Background Information
  • Uniprot Id

    Q5VW38

  • Target Species

    Human

  • Target Name

    GPR107

  • Target Full Name

    Protein GPR107

  • Target Function

    Has been proposed to act as a receptor for neuronostatin, a peptide derived from the somatostatin/SST precursor. Involved in blood sugar regulation through the induction of glucagon in response to low glucose.; (Microbial infection) Required for intoxication by Pseudomonas aeruginosa exotoxin A and Campylobacter jejuni CDT. May contribute to the retrograde transport of bacterial toxins, including cholera toxin, from the trans-Golgi network to the endoplasmic reticulum.

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein. Golgi apparatus, trans-Golgi network membrane.

  • Target Protein Families

    LU7TM family

  • Target Research Area

    Others

  • Target Synonyms

    GPR107; KIAA1624; LUSTR1; Protein GPR107; Lung seven transmembrane receptor 1

Inquire Recombinant Human Protein GPR107 (GPR107), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification